SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-21-000003
Filing Date
2021-02-10
Accepted
2021-02-10 13:27:56
Documents
83
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20201231x10q.htm 10-Q 1197848
2 EX-31.1 veru-20201231xex31_1.htm EX-31.1 15662
3 EX-31.2 veru-20201231xex31_2.htm EX-31.2 15887
4 EX-32.1 veru-20201231xex32_1.htm EX-32.1 11672
  Complete submission text file 0000863894-21-000003.txt   6473479

Data Files

Seq Description Document Type Size
5 EX-101.INS veru-20201231.xml EX-101.INS 1390479
6 EX-101.SCH veru-20201231.xsd EX-101.SCH 64005
7 EX-101.CAL veru-20201231_cal.xml EX-101.CAL 71574
8 EX-101.DEF veru-20201231_def.xml EX-101.DEF 198253
9 EX-101.LAB veru-20201231_lab.xml EX-101.LAB 453230
10 EX-101.PRE veru-20201231_pre.xml EX-101.PRE 378082
Mailing Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127
Business Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 21612798
SIC: 2834 Pharmaceutical Preparations